Leukotrap Wb System
NDC Package 53157-262-01

View Billable Units, 11-Digit Conversion Format, and RxNorm mappings
Table of Contents
    1. Package Information
    2. Frequently Asked Questions

Package Information

This product is EXCLUDED from the official NDC directory because the listing data was inactivated by the FDA.

Leukotrap Wb System is a . Marketed by Haemonetics Corporation, this product is identified by NDC 53157-262 and is authorized under FDA application BN820915.

Identification & Billing

NDC Package Code
53157-262-01
Package Description
1 KIT in 1 KIT * 63 mL in 1 BAG * 100 mL in 1 BAG
Product Code
53157-262
11-Digit Billing Format
53157026201

Clinical Specifications

Proprietary Name
Leukotrap Wb System
Dosage Form
-

Regulatory & Marketing

Labeler Name
Haemonetics Corporation
FDA Application #
BN820915
Marketing Category
NDA - A product marketed under an approved New Drug Application.
Start Marketing Date
09-22-1983
Listing Expiration
12-31-2024
Exclude Flag
I
Sample Package
No

Hierarchy Structure

Code Lineage

The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.

* Please review the full disclaimer at the bottom of this page.

Frequently Asked Questions

What is the distribution configuration for this product package?

The code 53157-262-01 identifies a specific commercial package of 1 kit in 1 kit * 63 ml in 1 bag * 100 ml in 1 bag of Leukotrap Wb System, labeled by Haemonetics Corporation. This is formulated for use and contains as the active substance.

Is this product currently listed with the FDA?

This product code is currently listed as inactive or excluded from the primary directory. It was introduced to the market by Haemonetics Corporation on September 22, 1983. The current certification is valid through December 31, 2024.

How is this Haemonetics Corporation product billed for insurance claims?

For medical billing and reimbursement, this package follows the 11-digit CMS format: 53157026201. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.

11-Digit Code Conversion

Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:

10-Digit Format (5-3-2)
53157-262-01
11-Digit CMS (5-4-2)
53157-0262-01

Note: The zero is added to the Product segment to maintain the 5-4-2 structure.